Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) with Competitors
Qualigen Therapeutics, Inc. Common Stock (QLGN) industry is Biotechnology.
Profit Margin
QLGN-38.25%
Industry-0.13%
Upside-38.12%
Operating Margin
QLGN-59.58%
Industry-2073.25%
Upside+2013.67%
Debt-to-Equity
QLGN8.40%
Industry29.76%
Upside-71.77%
P/E
QLGN-0.44
Industry-18.88
Upside+1843.83%
P/S
QLGN1.12
Industry9.28
Upside-87.95%
P/B
QLGN0.05
Industry4.70
Upside-98.85%